Logo image of OXUR.BR

OXURION NV (OXUR.BR) Stock Fundamental Analysis

Europe - Euronext Brussels - EBR:OXUR - BE0974487192 - Common Stock

0.0096 EUR
+0 (+4.35%)
Last: 12/8/2025, 7:00:00 PM
Fundamental Rating

2

OXUR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 83 industry peers in the Biotechnology industry. OXUR may be in some trouble as it scores bad on both profitability and health. OXUR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year OXUR was profitable.
OXUR had a negative operating cash flow in the past year.
In the past 5 years OXUR reported 4 times negative net income.
In the past 5 years OXUR always reported negative operating cash flow.
OXUR.BR Yearly Net Income VS EBIT VS OCF VS FCFOXUR.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M

1.2 Ratios

Looking at the Return On Assets, with a value of 39.34%, OXUR belongs to the top of the industry, outperforming 98.80% of the companies in the same industry.
Industry RankSector Rank
ROA 39.34%
ROE N/A
ROIC N/A
ROA(3y)-183.9%
ROA(5y)-157.58%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OXUR.BR Yearly ROA, ROE, ROICOXUR.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K 4K

1.3 Margins

OXUR has a better Profit Margin (97950.00%) than 100.00% of its industry peers.
OXUR has a Operating Margin of 45050.00%. This is amongst the best in the industry. OXUR outperforms 100.00% of its industry peers.
Industry RankSector Rank
OM 45050%
PM (TTM) 97950%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OXUR.BR Yearly Profit, Operating, Gross MarginsOXUR.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5K -5K 10K

More info and screens

0

2. Health

2.1 Basic Checks

OXUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OXUR has more shares outstanding
The number of shares outstanding for OXUR has been increased compared to 5 years ago.
OXUR has a worse debt/assets ratio than last year.
OXUR.BR Yearly Shares OutstandingOXUR.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
OXUR.BR Yearly Total Debt VS Total AssetsOXUR.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -27.35, we must say that OXUR is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of OXUR (-27.35) is worse than 83.13% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -27.35
ROIC/WACCN/A
WACC1.94%
OXUR.BR Yearly LT Debt VS Equity VS FCFOXUR.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

OXUR has a Current Ratio of 0.17. This is a bad value and indicates that OXUR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of OXUR (0.17) is worse than 93.98% of its industry peers.
OXUR has a Quick Ratio of 0.17. This is a bad value and indicates that OXUR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.17, OXUR is not doing good in the industry: 93.98% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.17
Quick Ratio 0.17
OXUR.BR Yearly Current Assets VS Current LiabilitesOXUR.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 101.88% over the past year.
OXUR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -97.62%.
OXUR shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -76.22% yearly.
EPS 1Y (TTM)101.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%84.92%
Revenue 1Y (TTM)-97.62%
Revenue growth 3Y-86.15%
Revenue growth 5Y-76.22%
Sales Q2Q%-100%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OXUR.BR Yearly Revenue VS EstimatesOXUR.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
OXUR.BR Yearly EPS VS EstimatesOXUR.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 -2K -4K -6K -8K -10K

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 0.02, the valuation of OXUR can be described as very cheap.
100.00% of the companies in the same industry are more expensive than OXUR, based on the Price/Earnings ratio.
OXUR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.34.
Industry RankSector Rank
PE 0.02
Fwd PE N/A
OXUR.BR Price Earnings VS Forward Price EarningsOXUR.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

81.93% of the companies in the same industry are more expensive than OXUR, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.79
OXUR.BR Per share dataOXUR.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

OXUR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OXURION NV

EBR:OXUR (12/8/2025, 7:00:00 PM)

0.0096

+0 (+4.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)09-30 2025-09-30
Earnings (Next)04-03 2026-04-03/amc
Inst Owners0.22%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap600.96K
Revenue(TTM)2.00K
Net Income(TTM)1.96M
Analysts42.22
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.02
Fwd PE N/A
P/S 300.48
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 11.79
EPS(TTM)0.61
EY6354.17%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS-0.19
TBVpS-0.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 39.34%
ROE N/A
ROCE -7.59%
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 45050%
PM (TTM) 97950%
GM N/A
FCFM N/A
ROA(3y)-183.9%
ROA(5y)-157.58%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 4.92
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.17
Quick Ratio 0.17
Altman-Z -27.35
F-Score4
WACC1.94%
ROIC/WACCN/A
Cap/Depr(3y)1.58%
Cap/Depr(5y)3.23%
Cap/Sales(3y)3.43%
Cap/Sales(5y)3.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)101.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%84.92%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-97.62%
Revenue growth 3Y-86.15%
Revenue growth 5Y-76.22%
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y112.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y87.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y87.87%
OCF growth 3YN/A
OCF growth 5YN/A

OXURION NV / OXUR.BR FAQ

What is the ChartMill fundamental rating of OXURION NV (OXUR.BR) stock?

ChartMill assigns a fundamental rating of 2 / 10 to OXUR.BR.


What is the valuation status of OXURION NV (OXUR.BR) stock?

ChartMill assigns a valuation rating of 3 / 10 to OXURION NV (OXUR.BR). This can be considered as Overvalued.


Can you provide the profitability details for OXURION NV?

OXURION NV (OXUR.BR) has a profitability rating of 3 / 10.


What are the PE and PB ratios of OXURION NV (OXUR.BR) stock?

The Price/Earnings (PE) ratio for OXURION NV (OXUR.BR) is 0.02 and the Price/Book (PB) ratio is -0.05.